Ann: Partnership provides funding for cutting-edge facility, page-47

In PIQ presentations , the revenue model for Pd was represented as a royalty of approx $5.50
per test per year ....arriving at an impressive total potential revenue $539 m...




I guess this is based on an average testing requirements of people affected by diabetes ...what we don't know
is how this relates to different groups according to risk....

Patia has given us a indication of the different testing requirements depending on your risk of developing CKD...as
indicated by Pd
The Pd test classifies people into three classes of risk ....high , medium , low ...



http://www.patiadiabetes.com/en/promarkerd-predicting-diabetic-kidney-disease/

I'm assuming the higher testing rates that are required for moderate and high risk groups is due to the rapid deterioration
of the kidneys and thus doctors need to closely monitor patients.....and not the efficacy of the test
Admittedly.... we don't really know the wording of the deal between PIQ and Patia ...but the Patia model
would indicate a higher revenue model for PIQ than indicated....

any thoughts....glta